Company Filing History:
1 out of 64 
1 out of 27 
1 out of 1 Years Active: 2011-2012
Title: Afshin Samali: Innovator in Cardiovascular Treatment and Cytokine Design
Introduction
Afshin Samali is a notable inventor based in Galway, Ireland. He has made significant contributions to the fields of cardiovascular disease treatment and protein design. With a total of 2 patents, his work has the potential to impact medical science profoundly.
Latest Patents
One of his latest patents is titled "Osteopontin for the prediction and treatment of cardiovascular diseases." This invention focuses on the use of endothelial progenitor cells (EPCs) and osteopontin for treating cardiovascular diseases or complications. It also highlights the use of EPC osteopontin levels as a marker for the risk of developing these complications. The invention provides compositions and methods based on osteopontin and the genes encoding it. Another significant patent is "Cytokine design," which relates to novel methods for designing proteins, particularly cytokines. These methods enable the stabilization of cytokines and modification of their selectivity and specificity for their cognate receptors. The invention also includes various modified proteins designed using these methods.
Career Highlights
Afshin Samali has worked with prestigious organizations such as the European Molecular Biology Laboratory and the National University of Ireland. His experience in these institutions has contributed to his expertise in the field of biomedical research.
Collaborations
He has collaborated with notable coworkers, including Vicente R Tur and Albert Martinus Van Der Sloot. These partnerships have likely enriched his research and innovation efforts.
Conclusion
Afshin Samali's contributions to the fields of cardiovascular treatment and protein design demonstrate his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving health outcomes through research and invention.